Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic Research AUSTIN, TX – October 2, 2025 – Tekton Research, a leading multi-site clinical trial company, is pleased to announce the promotion of Corey A. Collins to Chief Executive Officer (CEO). Collins joined Tekton in December 2023 as Chief Financial Officer, … Read more
Growth supports Tekton’s strategic focus on CNS and Cardiometabolic research AUSTIN, TX – September 26, 2025 – Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its expanding network. These … Read more
Clinical trials are essential to advancing medicine, bringing new therapies from discovery to approval. Traditionally, these trials have been centered in academic institutions and large hospitals—but embedded research site networks like Tekton help make trials accessible within community-based settings, where patients are being treated every day. As a trusted partner … Read more
Austin, TX – June 10, 2025 – Tekton Research continues its strategic growth in 2025 with the addition of its fourth new research site this year. The latest partnership is with Richmond Pediatric Associates, a respected multi-physician clinic in Virginia known for delivering comprehensive care across pediatric and adolescent populations. … Read more
Midlothian, VA — Tekton Research is proud to welcome Ben Phillips, MD, a board-certified endocrinologist and leader in diabetes, obesity, and osteoporosis care, as a Principal Investigator. This partnership expands Tekton’s clinical research footprint into the Midlothian and Richmond, Virginia region. With over 25 years of clinical experience, Dr. Phillips … Read more
Each year on May 20, we pause to honor Clinical Trials Day–a global recognition of the people, partnerships and progress that make clinical research possible. This day marks the anniversary of the first randomized clinical trial, conducted in 1747 by James Lind, and serves as a moment to reflect on … Read more
Saint Louis, MO – Tekton Research is proud to announce its partnership with Dr. Ernest A. Graypel, a highly regarded psychiatrist and researcher, Board Certified in Psychiatry and Neurology. This effort supports Tekton’s expanding capabilities in central nervous system (CNS) research, particularly in Behavioral Health sciences. As the Medical Director … Read more
As we step into 2025, Tekton Research is proud to reflect on a year filled with growth, innovation, and impactful contributions to clinical research. Tekton extends their gratitude to everyone who played a role in advancing their mission. From the dedicated staff and PI’s, to CRO and biopharma partners, and … Read more
Subscribe to Inside Tekton on LinkedIn
Get Tekton's monthly newsletter that rounds up the latest from Tekton, and the clinical research landscape.